CRGX
Price:
$4.59
Market Cap:
$211.66M
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San M...[Read more]
Industry
Biotechnology
IPO Date
2023-11-13
Stock Exchange
NASDAQ
Ticker
CRGX
According to CARGO Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -58.44%. This represents a change of 270.17% compared to the average of -15.79% of the last 4 quarters.
The mean historical ROE of CARGO Therapeutics, Inc. Common Stock over the last ten years is 847.09%. The current -58.44% ROE has changed -106.90% with respect to the historical average. Over the past ten years (40 quarters), CRGX's ROE was at its highest in in the December 2022 quarter at 39.02%. The ROE was at its lowest in in the March 2025 quarter at -29.92%.
Average
847.09%
Median
46.00%
Minimum
-46.50%
Maximum
3.34%
Discovering the peaks and valleys of CARGO Therapeutics, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.06%
Maximum Annual ROE = 3.34%
Minimum Annual Increase = -120.83%
Minimum Annual ROE = -46.50%
Year | ROE | Change |
---|---|---|
2024 | -46.50% | 92.06% |
2023 | -24.21% | -120.83% |
2022 | 116.22% | -96.52% |
The current ROE of CARGO Therapeutics, Inc. Common Stock (CRGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.17%
5-year avg
847.09%
10-year avg
847.09%
CARGO Therapeutics, Inc. Common Stock’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CARGO Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CARGO Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CARGO Therapeutics, Inc. Common Stock's ROE?
How is the ROE calculated for CARGO Therapeutics, Inc. Common Stock (CRGX)?
What is the highest ROE for CARGO Therapeutics, Inc. Common Stock (CRGX)?
What is the 3-year average ROE for CARGO Therapeutics, Inc. Common Stock (CRGX)?
What is the 5-year average ROE for CARGO Therapeutics, Inc. Common Stock (CRGX)?
How does the current ROE for CARGO Therapeutics, Inc. Common Stock (CRGX) compare to its historical average?